PLIANT THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Pliant Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Pliant Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $154M, a 45.7% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $154M +$48.3M +45.7% Dec 31, 2023 10-K 2024-02-27
Q4 2022 $106M +$38M +56.1% Dec 31, 2022 10-K 2024-02-27
Q4 2021 $67.7M +$32.2M +91% Dec 31, 2021 10-K 2024-02-27
Q4 2020 $35.4M +$13.5M +61.6% Dec 31, 2020 10-K 2023-03-09
Q4 2019 $21.9M +$1.69M +8.35% Dec 31, 2019 10-K 2022-03-01
Q4 2018 $20.2M Dec 31, 2018 10-K 2021-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.